Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Binghuo Gout Compound
- Development stage
- Unknown
- Lead developer
- Sichuan Sunnyhope Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
槟藿痛风合剂 (Binghuo Gout Compound) is a proprietary traditional Chinese medicine (TCM) oral liquid formulation developed and manufactured by Sichuan Sunnyhope Pharmaceutical. It is indicated for the treatment of gout and is recognized as an exclusive TCM variety in China. The preparation is part of the company's core product line, which focuses on gout specialty drugs and essential medicines. As a TCM mixture (Heji), it utilizes a combination of herbal ingredients to manage gout symptoms and potentially regulate uric acid levels through multi-target anti-inflammatory and metabolic pathways common in traditional herbal medicine.
- Brand names
- 槟藿痛风合剂
- Other names
- Binghuo Tongfeng HejiBinghuo Gout Mixture
Beyond the preview
Go deeper on Binghuo Gout Compound.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Binghuo Gout Compound.